Page last updated: 2024-11-01

nifedipine and Bladder Diseases

nifedipine has been researched along with Bladder Diseases in 6 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"As hypertension (HT) is one of the risk factors for lower urinary tract symptoms, we investigated the effect of an angiotensin II type I receptor blocker, olmesartan, on bladder dysfunction in the spontaneously hypertensive rat (SHR)."3.80Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress. ( Dimitriadis, F; Kinoshita, Y; Martin, DT; Ohmasa, F; Oikawa, R; Oiwa, H; Saito, M; Satoh, I; Shimizu, S; Tomita, S; Tsounapi, P, 2014)
"Bladder function of db/db (type 2 diabetes) and wild type (Wt) mice was evaluated by behavioral tests and in vivo cystometry."1.40T- and L-type voltage-gated calcium channels: their role in diabetic bladder dysfunction. ( Chitaley, K; Jiang, X; Luttrell, I; Yang, CC, 2014)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, X1
Luttrell, I1
Chitaley, K1
Yang, CC1
Shimizu, S1
Saito, M1
Oiwa, H1
Ohmasa, F1
Tsounapi, P1
Oikawa, R1
Dimitriadis, F1
Martin, DT1
Satoh, I1
Kinoshita, Y1
Tomita, S1
Yono, M1
Yoshida, M1
Yamamoto, Y1
Imanishi, A1
Fukagawa, A1
Latifpour, J1
Eto, M1
Leiria, LO1
Mónica, FZ1
Carvalho, FD1
Claudino, MA1
Franco-Penteado, CF1
Schenka, A1
Grant, AD1
De Nucci, G1
Antunes, E1
Levin, RM1
Kitada, S1
Hayes, L1
Kau, ST1
Fromm-Freeck, S1
Howe, BB1
Wein, AJ1
Kontani, H1
Nakagawa, M1
Takeno, S1
Sakai, T1

Other Studies

6 other studies available for nifedipine and Bladder Diseases

ArticleYear
T- and L-type voltage-gated calcium channels: their role in diabetic bladder dysfunction.
    Neurourology and urodynamics, 2014, Volume: 33, Issue:1

    Topics: Acetylcholine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type

2014
Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
    Neurourology and urodynamics, 2014, Volume: 33, Issue:3

    Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Bl

2014
Identification of potential therapeutic targets in hypertension-associated bladder dysfunction.
    BJU international, 2010, Volume: 105, Issue:6

    Topics: Analysis of Variance; Animals; Antihypertensive Agents; Doxazosin; Gene Expression; Gene Expression

2010
Functional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: evidence of a role for L-type voltage-operated Ca2+ channels.
    British journal of pharmacology, 2011, Volume: 163, Issue:6

    Topics: Amides; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Chloride; Carbachol; Ch

2011
Experimental hyperreflexia: effect of intravesical administration of various agents.
    Pharmacology, 1991, Volume: 42, Issue:1

    Topics: Animals; Benzopyrans; Blood Pressure; Cromakalim; Diltiazem; Electric Stimulation; Electromyography;

1991
Evaluation of drugs for treatment of urinary bladder dysfunction in conscious rats with intact pelvic nerve and after resection of the left pelvic nerve.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:4

    Topics: Animals; Atropine; Butylamines; Decerebrate State; Drug Evaluation; Male; Mandelic Acids; Nifedipine

1990